Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3671841012 | Product containing scopolamine in transdermal dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3671842017 | Product containing scopolamine in transdermal dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3671843010 | Scopolamine in transdermal dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3671844016 | Hyoscine in transdermal dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3711841013 | Scopolamine-containing product in transdermal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3711842018 | Product containing scopolamine in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3711843011 | Hyoscine-containing product in transdermal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hyoscine-containing product in transdermal dose form | Is a | Hyoscine-containing product | true | Inferred relationship | Some | ||
| Hyoscine-containing product in transdermal dose form | Is a | Product manufactured as transdermal dose form | true | Inferred relationship | Some | ||
| Hyoscine-containing product in transdermal dose form | Has active ingredient | Hyoscine | true | Inferred relationship | Some | 1 | |
| Hyoscine-containing product in transdermal dose form | Has manufactured dose form | Transdermal dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hyoscine only product in transdermal dose form | Is a | True | Hyoscine-containing product in transdermal dose form | Inferred relationship | Some | |
| Scopolamine 0.5mg/24 hr patch | Is a | False | Hyoscine-containing product in transdermal dose form | Inferred relationship | Some | |
| Hyoscine 13.889 microgram/hour prolonged-release transdermal patch | Is a | False | Hyoscine-containing product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets